163 related articles for article (PubMed ID: 23055188)
1. Different effects of ERβ and TROP2 expression in Chinese patients with early-stage colon cancer.
Fang YJ; Wang GQ; Lu ZH; Zhang L; Li JB; Wu XJ; Ding PR; Ou QJ; Zhang MF; Jiang W; Pan ZZ; Wan DS
Tumour Biol; 2012 Dec; 33(6):2227-35. PubMed ID: 23055188
[TBL] [Abstract][Full Text] [Related]
2. Impact of ERβ and CD44 expression on the prognosis of patients with stage II colon cancer.
Fang YJ; Zhang L; Wu XJ; Lu ZH; Li JB; Ou QJ; Zhang MF; Ding PR; Pan ZZ; Wan DS
Tumour Biol; 2012 Dec; 33(6):1907-14. PubMed ID: 22836803
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of ERβ and MMP7 expression on overall survival in colon cancer.
Fang YJ; Lu ZH; Wang F; Wu XJ; Li LR; Zhang LY; Pan ZZ; Wan DS
Tumour Biol; 2010 Dec; 31(6):651-8. PubMed ID: 20680712
[TBL] [Abstract][Full Text] [Related]
4. Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer.
Fang YJ; Lu ZH; Wang GQ; Pan ZZ; Zhou ZW; Yun JP; Zhang MF; Wan DS
Int J Colorectal Dis; 2009 Aug; 24(8):875-84. PubMed ID: 19421758
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of TROP2 expression in patients with gallbladder cancer.
Chen MB; Wu HF; Zhan Y; Fu XL; Wang AK; Wang LS; Lei HM
Tumour Biol; 2014 Nov; 35(11):11565-9. PubMed ID: 25135430
[TBL] [Abstract][Full Text] [Related]
6. TROP2 expression and its evolving role in tumor pathogenesis in systemic tumors.
Kapoor S
Tumour Biol; 2013 Jun; 34(3):1967-8. PubMed ID: 23150179
[No Abstract] [Full Text] [Related]
7. [Expression of TROP2 mRNA in left-sided and right-sided colon cancer and its clinical significance].
Xu KY; Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):285-9. PubMed ID: 19434540
[TBL] [Abstract][Full Text] [Related]
8. Clinical investigation of TROP-2 as an independent biomarker and potential therapeutic target in colon cancer.
Zhao P; Yu HZ; Cai JH
Mol Med Rep; 2015 Sep; 12(3):4364-4369. PubMed ID: 26059528
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
[TBL] [Abstract][Full Text] [Related]
10. Expression of voltage-gated sodium channel Nav1.5 in non-metastatic colon cancer and its associations with estrogen receptor (ER)-β expression and clinical outcomes.
Peng J; Ou Q; Wu X; Zhang R; Zhao Q; Jiang W; Lu Z; Wan D; Pan Z; Fang Y
Chin J Cancer; 2017 Nov; 36(1):89. PubMed ID: 29122010
[TBL] [Abstract][Full Text] [Related]
11. TROP2 expression as prognostic marker for gastric carcinoma.
Mühlmann G; Spizzo G; Gostner J; Zitt M; Maier H; Moser P; Gastl G; Zitt M; Müller HM; Margreiter R; Ofner D; Fong D
J Clin Pathol; 2009 Feb; 62(2):152-8. PubMed ID: 18930986
[TBL] [Abstract][Full Text] [Related]
12. TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity.
Fong D; Spizzo G; Gostner JM; Gastl G; Moser P; Krammel C; Gerhard S; Rasse M; Laimer K
Mod Pathol; 2008 Feb; 21(2):186-91. PubMed ID: 18084248
[TBL] [Abstract][Full Text] [Related]
13. Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation.
Zhang B; Gao S; Li R; Li Y; Cao R; Cheng J; Guo Y; Wang E; Huang Y; Zhang K
BMC Cancer; 2020 Aug; 20(1):815. PubMed ID: 32854652
[TBL] [Abstract][Full Text] [Related]
14. Surveillance for early stages of colon cancer: potentials for optimizing follow-up protocols.
Gilardoni E; Bernasconi DP; Poli S; Garancini M; Luperto M; Zucchini N; Bovo G; Totis M; Bugatti A; Gianotti L
World J Surg Oncol; 2015 Aug; 13():260. PubMed ID: 26311420
[TBL] [Abstract][Full Text] [Related]
15. The role and molecular mechanism of Trop2 induced epithelial-mesenchymal transition through mediated β-catenin in gastric cancer.
Zhao W; Jia L; Kuai X; Tang Q; Huang X; Yang T; Qiu Z; Zhu J; Huang J; Huang W; Feng Z
Cancer Med; 2019 Mar; 8(3):1135-1147. PubMed ID: 30632714
[TBL] [Abstract][Full Text] [Related]
16. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
[TBL] [Abstract][Full Text] [Related]
17. TROP2 overexpression promotes proliferation and invasion of lung adenocarcinoma cells.
Li Z; Jiang X; Zhang W
Biochem Biophys Res Commun; 2016 Jan; 470(1):197-204. PubMed ID: 26773504
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer.
Peng RQ; Wu XJ; Ding Y; Li CY; Yu XJ; Zhang X; Pan ZZ; Wan DS; Zheng LM; Zeng YX; Zhang XS
BMC Cancer; 2010 Sep; 10():496. PubMed ID: 20846416
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of hedgehog signaling pathway in patients with colon cancer.
Xu M; Li X; Liu T; Leng A; Zhang G
Med Oncol; 2012 Jun; 29(2):1010-6. PubMed ID: 21424326
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of TROP2 in human nasopharyngeal carcinoma.
Guan GF; Zhang DJ; Wen LJ; Yu DJ; Zhao Y; Zhu L; Guo YY; Zheng Y
Int J Clin Exp Pathol; 2015; 8(9):10995-1004. PubMed ID: 26617817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]